Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor

Molecular Pharmacology

Volumn 80, Issue 3, 2011, Pages 416-425

  Espinoza, Stefano ^a   Salahpour, Ali ^c   Masri, Bernard ^d   Sotnikova, Tatyana D ^a   Messa, Mirko ^e   Barak, Larry S ^b   Caron, Marc G ^b   Gainetdinov, Raul R ^a,b  

^a ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d CANCER RESEARCH CENTER OF TOULOUSE   (France)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; CYCLIC AMP; DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR; HALOPERIDOL; HETERODIMER; LIGAND; PHENETHYLAMINE; PROTEIN C FOS; PROTEIN TRACE AMINE ASSOCIATED RECEPTOR 1; RACLOPRIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; BIOSENSOR; CELL STRAIN HEK293; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; DIMERIZATION; FLUORESCENT ANTIBODY TECHNIQUE; HALOPERIDOL; HUMANS; LIGANDS; MICE; MICE, INBRED C57BL; PROTEIN BINDING; RECEPTORS, DOPAMINE D2; RECEPTORS, G-PROTEIN-COUPLED;

EID: 80052007530     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.111.073304     Document Type: Article

References (41)

1. Angers S., Salahpour A, and Bouvier M. (2002) Dimerization: An emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol 42:409-435. (Pubitemid 34160532)
2. Baldessarini R.J. (1978) Trace amines and alternative neurotransmitters in the central nervous system. Biochem Pharmacol 27:621-626.
3. Barak L.S., Salahpour A., Zhang X., Masri B., Sotnikova T.D., Ramsey A.J., Violin J.D., Lefkowitz R.J., Caron MG, and Gainetdinov R.R. (2008) Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor. Mol Pharmacol 74:585-594.
4. Beaulieu JM and Gainetdinov R.R. (2011) The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol Rev 63:182-217.
5. Berry M.D. (2004) Mammalian central nervous system trace amines. Pharmacologic amphetamines, physiologic neuromodulators. J Neurochem 90:257-271.
6. Borowsky B., Adham N., Jones K.A., Raddatz R., Artymyshyn R., Ogozalek K.L., Durkin M.M., Lakhlani P.P., Bonini J.A., Pathirana S., et al. (2001) Trace amines: Identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 98:8966-8971. (Pubitemid 32743853)
7. Bouvier M. (2001) Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci 2:274-286.
8. Bradaia A., Trube G., Stalder H., Norcross R.D., Ozmen L., Wettstein J.G., Pinard A., Buchy D., Gassmann M., Hoener M.C., et al. (2009) The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system. Proc Natl Acad Sci USA 106:20081-20086.
9. Breier A., Su T.P., Saunders R., Carson R.E., Kolachana B.S., De Bartolomeis A., Weinberger D.R., Weisenfeld N., Malhotra A.K., Eckelman W.C., et al. (1997) Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 94:2569-2574. (Pubitemid 27136916)
10. Bunzow J.R., Sonders M.S., Arttamangkul S., Harrison L.M., Zhang G., Quigley D.I., Darland T., Suchland K.L., Pasumamula S., Kennedy J.L., et al. (2001) Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. Mol Pharmacol 60:1181-1188. (Pubitemid 33144888)
11. Creese I., Burt DR, and Snyder S.H. (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481-483.
12. Dalrymple M.B., Pfleger KD, and Eidne K.A. (2008) G protein-coupled receptor dimers: Functional consequences, disease states and drug targets. Pharmacol Ther 118:359-371.
13. Davis BA and Boulton A.A. (1994) The trace amines and their acidic metabolites in depression-an overview. Prog Neuropsychopharmacol Biol Psychiatry 18:17-45.
14. DiPilato L.M., Cheng X, and Zhang J. (2004) Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. Proc Natl Acad Sci USA 101:16513-16518. (Pubitemid 39557744)
15. Dong C., Filipeanu C.M., Duvernay MT, and Wu G. (2007) Regulation of G protein-coupled receptor export trafficking. Biochim Biophys Acta 1768:853-870. (Pubitemid 46452538)
16. Grandy D.K. (2007) Trace amine-associated receptor 1-Family archetype or iconoclast? Pharmacol Ther 116:355-390.
17. Jones K.A., Borowsky B., Tamm J.A., Craig D.A., Durkin M.M., Dai M., Yao W.J., Johnson M., Gunwaldsen C., Huang L.Y., et al. (1998) GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 396:674-679. (Pubitemid 29003945)
18. Kaupmann K., Malitschek B., Schuler V., Heid J., Froestl W., Beck P., Mosbacher J., Bischoff S., Kulik A., Shigemoto R., et al. (1998) GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature 396:683-687. (Pubitemid 29003947)
19. Lindemann L and Hoener M.C. (2005) A renaissance in trace amines inspired by a novel GPCR family. Trends Pharmacol Sci 26:274-281. (Pubitemid 40603076)
20. Lindemann L., Meyer C.A., Jeanneau K., Bradaia A., Ozmen L., Bluethmann H., Bettler B., Wettstein J.G., Borroni E., Moreau J.L., et al. (2008) Trace amine-associated receptor 1 modulates dopaminergic activity. J Pharmacol Exp Ther 324:948-956. (Pubitemid 351397852)
21. Masri B., Salahpour A., Didriksen M., Ghisi V., Beaulieu J.M., Gainetdinov RR, and Caron M.G. (2008) Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics. Proc Natl Acad Sci USA 105:13656-13661.
22. McCabe B and Tsuang M.T. (1982) Dietary consideration in MAO inhibitor regimens. J Clin Psychiatry 43:178-181. (Pubitemid 12117410)
23. Miller G.M., Verrico C.D., Jassen A., Konar M., Yang H., Panas H., Bahn M., Johnson R, and Madras B.K. (2005) Primate trace amine receptor 1 modulation by the dopamine transporter. J Pharmacol Exp Ther 313:983-994. (Pubitemid 40727001)
24. Milligan G. (2009) G protein-coupled receptor hetero-dimerization: Contribution to pharmacology and function. Br J Pharmacol 158:5-14.
25. Möller H.J. (2003) Amisulpride: Limbic specificity and the mechanism of antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry 27:1101-1111.
26. Nguyen T.V., Kosofsky B.E., Birnbaum R., Cohen BM, and Hyman S.E. (1992) Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc Natl Acad Sci USA 89:4270-4274.
27. Pfleger KD and Eidne K.A. (2006) Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET). Nat Methods 3:165-174.
28. Ponsioen B., Zhao J., Riedl J., Zwartkruis F., Van der Krogt G., Zaccolo M., Moolenaar W.H., Bos JL, and Jalink K. (2004) Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator. EMBO Rep 5:1176-1180. (Pubitemid 40103613)
29. Revel F.G., Moreau J.L., Gainetdinov R.R., Bradaia A., Sotnikova T.D., Mory R., Durkin S., Zbinden K.G., Norcross R., Meyer C.A., et al. (2011) TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc Natl Acad Sci USA 108:8485-8490.
30. Sabelli HC and Mosnaim A.D. (1974) Phenylethylamine hypothesis of affective behavior. Am J Psychiatry 131:695-699.
31. Salahpour A., Angers S., Mercier J.F., Lagacé M., Marullo S, and Bouvier M. (2004) Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting. J Biol Chem 279:33390-33397. (Pubitemid 39062987)
32. Salahpour A and Masri B. (2007) Experimental challenge to a 'rigorous' BRET analysis of GPCR oligomerization. Nat Methods 4:599-600; author reply 601.
33. Sotnikova T.D., Beaulieu J.M., Barak L.S., Wetsel W.C., Caron MG, and Gainetdinov R.R. (2005) Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease. PLoS Biol 3:e271.
34. Sotnikova T.D., Beaulieu J.M., Espinoza S., Masri B., Zhang X., Salahpour A., Barak L.S., Caron MG, and Gainetdinov R.R. (2010) The dopamine metabolite 3-methoxytyramine is a neuromodulator. PLoS One 5:e13452.
35. Sotnikova T.D., Budygin E.A., Jones S.R., Dykstra L.A., Caron MG, and Gainetdinov R.R. (2004) Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine. J Neurochem 91:362-373. (Pubitemid 39363435)
36. Sotnikova T.D., Caron MG, and Gainetdinov R.R. (2009) Trace amine-associated receptors as emerging therapeutic targets. Mol Pharmacol 76:229-235.
37. Sotnikova T.D., Zorina O.I., Ghisi V., Caron MG, and Gainetdinov R.R. (2008) Trace amine associated receptor 1 and movement control. Parkinsonism Relat Disord 14 (Suppl 2):S99-S102.
38. Strange P.G. (2001) Antipsychotic drugs: Importance of dopamine receptors for mechanisms of therapeutic actions and side effects. Pharmacol Rev 53:119-133.
39. Violin J.D., DiPilato L.M., Yildirim N., Elston T.C., Zhang J, and Lefkowitz R.J. (2008) beta2-adrenergic receptor signaling and desensitization elucidated by quantitative modeling of real time cAMP dynamics. J Biol Chem 283:2949-2961.
40. White J.H., Wise A., Main M.J., Green A., Fraser N.J., Disney G.H., Barnes A.A., Emson P., Foord SM, and Marshall F.H. (1998) Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 396:679-682. (Pubitemid 29003946)
41. Wolinsky T.D., Swanson C.J., Smith K.E., Zhong H., Borowsky B., Seeman P., Branchek T, and Gerald C.P. (2007) The Trace Amine 1 receptor knockout mouse: An animal model with relevance to schizophrenia. Genes Brain Behav 6:628-639. (Pubitemid 47476185)